FDA Advise-ERR: FDA Approves Hydromorphone Labeling Revisions to Reduce Medication Errors;Differentiating Penicillin from Penicillamine;Infusion Reconnected to the Wrong Patient;Spell Out Acetaminophen on Prescription Labels

Abstract

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs.

Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below.

Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at ismpinfo@ismp.org. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications.

Get full access to this article

View all access options for this article.

References

Pennsylvania Patient Safety Authority. Adverse drug events with hydromorphone: how preventable are they? PA Patient Saf Advis. 2010; 7(3): 69–75.

Pennsylvania Patient Safety Authority. Common medication pairs that contribute to wrong drug errors. FA Patient Saf Advis. 2007; 4(3): 89.

Pennsylvania Patient Safety Authority. Inadvertent mix-up of morphine and hydromorphone: a potent error. FA Patient Saf Advis. 2007; 4(3): 86–88.

Institute for Safe Medication Practices. HYDROmorphone alert. ISMP Medication Safety Alert! 2007; 12(11): 1.

Institute for Safe Medication Practices. High-alert medication feature: reducing patient harm from opiates. ISMP Medication Safety Alert! 2007; 12(4): 1–3.

Institute for Safe Medication Practices. Risk of deadly mix-up exists in most hospitals. ISMP Medication Safety Alert! 2004; 9(13): 1–2.

Institute for Safe Medication Practices. Beware of basal opioid infusions with PCA therapy. ISMP Medication Safety Alert! 2009; 14(5): 1–3.

Institute for Safe Medication Practices. Investigation of naloxone use uncovered an error in converting oral HYDROmorphone to IV route. ISMP Medication Safety Alert! 2003; 8(10): 2.

Institute for Safe Medication Practices. Risk control strategies for reducing patient harm with HYDROmorphone. www.ismp.org/tools/hydromorphone.asp. Accessed June 16, 2011.

10.

US Food and Drug Administration. Name differentiation project. June 18, 2009. www.fda.gov/Drugs/DrugSafety/MedicationErrors/ucm164587.htm. Accessed June 16, 2011.